In Vitro Oral Cavity Permeability Assessment to Enable Simulation of Drug Absorption

In Vitro Oral Cavity Permeability Assessment to Enable Simulation of Drug Absorption

<b>Background/Objectives:</b> The oral cavity represents a convenient route of administration for drugs that exhibit significant hepatic first-pass extraction. In this study, the mucosal permeation properties of selected active pharmaceutical ingredients (APIs) incorporated into oral cav...

Full description

Saved in:

Bibliographic Details
Main Authors:	Pankaj Dwivedi, Priyata Kalra, Haiying Zhou, Khondoker Alam, Eleftheria Tsakalozou, Manar Al-Ghabeish, Megan Kelchen, Giovanni M. Pauletti
Format:	Article
Language:	English
Published:	MDPI AG 2025-07-01
Series:	Pharmaceutics
Subjects:	Oral cavity drug delivery sublingual buccal generic drug development
Online Access:	https://www.mdpi.com/1999-4923/17/7/924
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Extramedullary Plasmacytoma of the Oral Cavity: A Rare Case in the Buccal Mucosa
by: Armin Khaleghi, et al.
Published: (2025-01-01)

Bioavailability Enhancement and Formulation Technologies of Oral Mucosal Dosage Forms: A Review
by: Ildikó Bácskay, et al.
Published: (2025-01-01)

THE POSPONT RESULTS OF SWITCHING ON TOPIRAMAT GENERICS AT PATIENTS WITH EPILEPSY
by: I. G. Rudakova
Published: (2016-05-01)

MORPHOFUNCTIONAL STATE OF BUCCAL EPITHELIOCYTES IN LUNG CANCER PATIENTS
by: O. P. Bochkareva, et al.
Published: (2016-02-01)

International comparison of generic competition, prices, and usage trends: South Korea and G20 countries
by: Da Hye Lee, et al.
Published: (2025-05-01)

Buccal Absorption of Biopharmaceutics Classification System III Drugs: Formulation Approaches and Mechanistic Insights
by: Rayan Sabra, et al.
Published: (2024-12-01)

COMPARATIVE EVALUATION OF THE EFFICACY AND SAFETY OF VALPROIC ACID DERIVATIVES
by: O. L. Badalyan, et al.
Published: (2016-05-01)

COMPARATIVE EFFICACY OF COMBINED ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH MODERATE ARTERIAL HYPERTENSION ACCOMPANIED BY TYPE 2 DIABETES
by: E. I. Tarlovskaya, et al.
Published: (2016-01-01)

THE KARDIOKANON STUDY: A WAY TO SETTLE THE SUBJECT OF CLINICAL EQUIVALENCE OF GENERIC AND ORIGINAL DRUGS
by: S. Yu. Martsevich, et al.
Published: (2015-12-01)

A comparative study of the efficacy and safety of the original and generic orlistat in obese patients in the PROFIL register
by: A. V. Zakharova, et al.
Published: (2016-03-01)

Efficacy and potentiality of vitamins and micronutrients oral sprays supplementation (review)
by: A. G. Polivanova
Published: (2025-03-01)

Determinants of the generic’s prescription among general practitioners in Casablanca, Morocco: A cross-sectional study
by: Boubacar Traore, et al.
Published: (2025-06-01)

TREATMENT OF OSTEOPOROSIS: CLINICAL EXPERIENCE IN USING A GENERIC DRU
by: Nataliya Vladimirovna Toroptsova, et al.
Published: (2011-03-01)

Assessment of in Vitro Comparative Dissolution Kinetics of Moxonidine Products as a Factor Potentially Determining Effectiveness of Antihypertensive Treatment
by: G. V. Ramenskaya, et al.
Published: (2019-01-01)

STUDY OF CLINICAL EFFICACY OF ORIGINAL AND GENERIC DRUGS OF IVABRADINE IN PATIENTS WITH STABLE ANGINA (СOMPARATIVE STUDY)
by: S. V. Povetkin, et al.
Published: (2018-03-01)

THERAPEUTIC EQUIVALENCE OF ORIGINAL CLOPIDOGREL (PLAVIX) AND ITS GENERIC (EGITROMB). RESULTS OF COMPARATIVE RANDOMIZED CROSS-OVER BLIND STUDY
by: V. V. Yakusevich, et al.
Published: (2016-01-01)

COMPETITION ON THE WHOLESALE MEDICATION DISTRIBUTION MARKET IN ROMANIA
by: Alina HAGIU, et al.
Published: (2013-09-01)

Medicines for people. Myths and reality
by: A. S. Petrukhin
Published: (2022-01-01)

A COMPARATIVE STUDY OF EFFICACY AND TOLERABILITY OF ORIGINAL AND GENERIC SIMVASTATIN IN PATIENTS WITH HYPERLIPIDEMIA
by: V. P. Voronina, et al.
Published: (2016-01-01)

ACETYLSALICYLIC ACID IN LOW DOSES FOR SECONDARY PREVENTION OF CARDIO-VASCULAR COMPLICATIONS
by: N. A. Dmitrieva, et al.
Published: (2016-01-01)

WHAT IS THERAPEUTIC EQUIVALENCE OF GENERIC DRUG AND HOW TO PROVE IT
by: N. P. Kutishenko, et al.
Published: (2016-01-01)

COMPARISON OF NEW GENERIC AND ORIGINAL RAMIPRIL IN PATIENTS WITH ARTERIAL HYPERTENSION AND HIGH CARDIOVASCULAR RISK
by: S. Yu. Martsevich, et al.
Published: (2016-01-01)

ACHIEVEMENT OF TARGET BLOOD PRESSURE LEVEL IN HYPERTENSIVE PATIENTS WITH AMLODIDINE: ORIGINAL DRUG VERSUS GENERIC
by: S. Yu. Martsevich, et al.
Published: (2016-01-01)

A Study on Health Experiences of the Social Classes in Terms of Drugs
by: Hatice Özer
Published: (2020-12-01)

COMPARISON OF ANTIPLATELET EFFECT AND SAFETY OF ORIGINAL DRUG «ASPIRIN CARDIO» AND GENERIC«ACECARDOL» IN PATIENTS WITH ARTERIAL HYPERTENSION 1-2 GRADE
by: N. A. Belolipetskiy, et al.
Published: (2016-01-01)

QUALITATIVE DRUG: WHAT SHOULD IT LOOK LIKE?
by: V. V. Iakusevich
Published: (2016-01-01)

Optimization of drug supply for patients with malignant neoplasms in a region of the Russian Federation
by: A. V. Nikitina, et al.
Published: (2020-02-01)

RETROSPECTIVE OF DISSOLUTION TEST OF SOLID DOSAGE FORMS (REVIEW)
by: D. Yu. Grebenkin, et al.
Published: (2019-01-01)

The problem of choice: original drug or generic? Emphasis on rosuvastatin
by: O. A. Polyakova, et al.
Published: (2022-05-01)

COMPARATIVE EFFICACY AND SAFETY OF HYPOLIPIDEMIC THERAPY WITH GENERIC AND ORIGINAL MEDICINAL PRODUCTS OF SIMVASTATIN
by: E. I. Tarlovskaya, et al.
Published: (2016-01-01)

ASSESSMENT OF THERAPEUTICAL EQUIVALENCY OF ORIGINAL AND GENERIC INDAPAMIDE IN HYPERTENSIVE PATIENTS BY RANDOMIZED CROSS-OVER STUDY
by: N. P. Kutishenko, et al.
Published: (2015-12-01)

STATIN GENERICS: EFFICACY AND SAFETY RATIO
by: V. P. Voronina, et al.
Published: (2016-01-01)

THE PROBLEM OF MEDICINES INTERCHANGEABILITY. FOCUS ON PERINDOPRIL
by: A. I. Malyhina, et al.
Published: (2015-09-01)

MODERN APPROACHES OF DISSOLUTION PROFILE TEST (REVIEW)
by: D. Yu. Grebenkin, et al.
Published: (2019-01-01)

Antipsychotics use in the community of Thessaloniki, Greece
by: Papaioannidou Paraskevi, et al.
Published: (2018-01-01)

Registration of Medicines in the Soviet Control and Licensing System on the Example of the Cardiological Drug Trinitrolong
by: A. N. Petrenko, et al.
Published: (2021-03-01)

TREATMENT EFFECTIVENESS AND SAFETY OF THE ORIGINAL AND GENERIC BISOPROLOL IN PATIENTS WITH ISCHEMIC HEART DISEASE
by: E. I. Tarlovskaya, et al.
Published: (2015-12-01)

Comparative analysis of thrombocytopenia incidence in patients treated with generic vs. brand-name linezolid: a cohort study utilizing hospital electronic medical records
by: Zhizhou Wang, et al.
Published: (2025-06-01)

Development of Drug-Device Combination Products and Generic Substitution in the United States
by: YoonJung Lee, et al.
Published: (2025-07-01)

Assessing α-Bisabolol as a Transmucosal Permeation Enhancer of Buccal Local Anesthetics
by: Renê Oliveira do Couto, et al.
Published: (2024-09-01)